De Novo · Granted
GrantedGili Pro BioSensor (also known as “Gili BioSensor System”)
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Continuse Biometrics, Ltd. · QOK Hardware And Software For Optical Camera-Based Measurement Of Heart Rate And Respiratory Rate
Granted on Apr 1, 2021 as a new device type through De Novo after a 293-day review. 1 later device descends from it.
- Decided
- Apr 1, 2021
- Review
- 293 days
- Class
- Class II
- Product code
- QOK
- Recalls
- None
1 later device descends from it, 1 citing it directly.
- This deviceDEN200038 Gili Pro BioSensor (also known as “Gili BioSensor System”)Continuse Biometrics, Ltd. · 2021
- Descendant · cites it directly · 0 of its ownK254240 Echo-2Neko Health AB · 2026
Most influential descendants
Showing 1 of 1 · See all- K254240Echo-2Neko Health AB · 2026 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | DEN200038 | Gili Pro BioSensor (also known as “Gili BioSensor System”) | Continuse Biometrics, Ltd. | 2021 | — |
| +1 | K254240 | Echo-2 | Neko Health AB | 2026 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2026 | 1 | 0 |
Sources: FDA De Novo database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QOK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QOK device
- #1 K254240 Echo-2score 12.1 · 1 generation · no Class I recall
Does it have a predicate?
De Novo decisions do not claim a predicate device.
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K254240 | Echo-2 | 2026 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K254240 (Neko Health AB, 2026) has gone furthest, with 0 descendants of its own.
How does its category compare?
All QOK devicesQOK Hardware And Software For Optical Camera-Based Measurement Of Heart Rate And Respiratory Rate: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.
FDA decisions per year · QOK
1in 2021
2026 to Oct 25, outlined.
Median 510(k) review, days · QOK
Too few QOK 510(k)s in any year since 2007 to give a median.
Recalls per year · QOK
No recall names QOK since 2007.
Adverse event reports per year · QOK
No MAUDE report names QOK since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 1 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 1 | — | 0 | — |
What is it indicated for?
The Gili Pro BioSensor (Gili BioSensor System) includes an optical module that is intended to capture motion-vibration signals from an illuminated surface for assessment of physiological information. Such information, captured during spot-measurement, includes:
• Heart rate
• Respiratory rate
The device is indicated for use by or under the supervision of healthcare professionals for adult patients in a hospital, outpatient, or other medical care settings, or for clinical research purposes.
The device should be used while the subject is seated upright either in a chair or in a bed. The information stored on the system may be reviewed by qualified persons.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/DEN200038 · printed Nov 6, 2026
Cite this page
510(k) Report. “DEN200038: Gili Pro BioSensor (also known as “Gili BioSensor System”).” Lineage record from FDA De Novo data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/DEN200038
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026